img

Global Patent Drug Market Insights, Forecast to 2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Patent Drug Market Insights, Forecast to 2034

A patent medicine is typically protected and advertised by a trademark and trade name (and sometimes a patent) and claimed to be effective against minor disorders and symptoms.
Market Analysis and InsightsGlobal Patent Drug Market
The global Patent Drug market is projected to grow from US$ million in 2024 to US$ million by 2034, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Patent Drug is estimated to increase from $ million in 2024 to reach $ million by 2034, at a CAGR of % during the forecast period of 2024 through 2034.
The China market for Patent Drug is estimated to increase from $ million in 2024 to reach $ million by 2034, at a CAGR of % during the forecast period of 2024 through 2034.
The Europe market for Patent Drug is estimated to increase from $ million in 2024 to reach $ million by 2034, at a CAGR of % during the forecast period of 2024 through 2034.
The global key companies of Patent Drug include Johnson & Johnson, Novartis, Roche, AbbVie, Merck & Co., Bristol Myers Squibb, GlaxoSmithKline, Pfizer and Sanofi, etc. in 2022, the global top five players had a share approximately % in terms of revenue.
Report Includes
This report presents an overview of global market for Patent Drug market size. Analyses of the global market trends, with historic market revenue data for 2018 - 2022, estimates for 2024, and projections of CAGR through 2034.
This report researches the key producers of Patent Drug, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Patent Drug, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Patent Drug revenue, market share and industry ranking of main companies, data from 2018 to 2024. Identification of the major stakeholders in the global Patent Drug market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, revenue, and growth rate, from 2018 to 2034. Evaluation and forecast the market size for Patent Drug revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Johnson & Johnson, Novartis, Roche, AbbVie, Merck & Co., Bristol Myers Squibb, GlaxoSmithKline, Pfizer and Sanofi, etc.



By Company


Johnson & Johnson
Novartis
Roche
AbbVie
Merck & Co.
Bristol Myers Squibb
GlaxoSmithKline
Pfizer
Sanofi
Takeda
AstraZeneca
Bayer
Eli Lilly & Co.
Gilead Sciences
Amgen
Novo Nordisk
Teva
Boehringer Ingelheim
Biogen
Astellas
Segment by Type
Oral
Injection
Other

Segment by Application


Hospital
Retail Pharmacy
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East, Africa, and Latin America
Turkey
Saudi Arabia
UAE
Rest of MEA

Chapter Outline


Chapter 1Introduces the report scope of the report, executive summary of different market segments (product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2Revenue of Patent Drug in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3Detailed analysis of Patent Drug companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6North America by type, by application and by country, revenue for each segment.
Chapter 7Europe by type, by application and by country, revenue for each segment.
Chapter 8China by type and by application revenue for each segment.
Chapter 9Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 10Middle East, Africa, and Latin America by type, by application and by country, revenue for each segment.
Chapter 11Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Patent Drug revenue, gross margin, and recent development, etc.
Chapter 12Analyst's Viewpoints/Conclusions

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Patent Drug Market Size Growth Rate by Type, 2018 VS 2022 VS 2034
1.2.2 Oral
1.2.3 Injection
1.2.4 Other
1.3 Market by Application
1.3.1 Global Patent Drug Market Size Growth Rate by Application, 2018 VS 2022 VS 2034
1.3.2 Hospital
1.3.3 Retail Pharmacy
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Patent Drug Market Perspective (2018-2034)
2.2 Global Patent Drug Growth Trends by Region
2.2.1 Patent Drug Market Size by Region: 2018 VS 2022 VS 2034
2.2.2 Patent Drug Historic Market Size by Region (2018-2024)
2.2.3 Patent Drug Forecasted Market Size by Region (2024-2034)
2.3 Patent Drug Market Dynamics
2.3.1 Patent Drug Industry Trends
2.3.2 Patent Drug Market Drivers
2.3.3 Patent Drug Market Challenges
2.3.4 Patent Drug Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Patent Drug by Players
3.1.1 Global Patent Drug Revenue by Players (2018-2024)
3.1.2 Global Patent Drug Revenue Market Share by Players (2018-2024)
3.2 Global Patent Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Patent Drug, Ranking by Revenue, 2021 VS 2022 VS 2024
3.4 Global Patent Drug Market Concentration Ratio
3.4.1 Global Patent Drug Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Patent Drug Revenue in 2022
3.5 Global Key Players of Patent Drug Head office and Area Served
3.6 Global Key Players of Patent Drug, Product and Application
3.7 Global Key Players of Patent Drug, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Patent Drug Breakdown Data by Type
4.1 Global Patent Drug Historic Market Size by Type (2018-2024)
4.2 Global Patent Drug Forecasted Market Size by Type (2024-2034)
5 Patent Drug Breakdown Data by Application
5.1 Global Patent Drug Historic Market Size by Application (2018-2024)
5.2 Global Patent Drug Forecasted Market Size by Application (2024-2034)
6 North America
6.1 North America Patent Drug Market Size (2018-2034)
6.2 North America Patent Drug Market Size by Type
6.2.1 North America Patent Drug Market Size by Type (2018-2024)
6.2.2 North America Patent Drug Market Size by Type (2024-2034)
6.2.3 North America Patent Drug Market Share by Type (2018-2034)
6.3 North America Patent Drug Market Size by Application
6.3.1 North America Patent Drug Market Size by Application (2018-2024)
6.3.2 North America Patent Drug Market Size by Application (2024-2034)
6.3.3 North America Patent Drug Market Share by Application (2018-2034)
6.4 North America Patent Drug Market Size by Country
6.4.1 North America Patent Drug Market Size by Country: 2018 VS 2022 VS 2034
6.4.2 North America Patent Drug Market Size by Country (2018-2024)
6.4.3 North America Patent Drug Market Size by Country (2024-2034)
6.4.4 United States
6.4.5 Canada
7 Europe
7.1 Europe Patent Drug Market Size (2018-2034)
7.2 Europe Patent Drug Market Size by Type
7.2.1 Europe Patent Drug Market Size by Type (2018-2024)
7.2.2 Europe Patent Drug Market Size by Type (2024-2034)
7.2.3 Europe Patent Drug Market Share by Type (2018-2034)
7.3 Europe Patent Drug Market Size by Application
7.3.1 Europe Patent Drug Market Size by Application (2018-2024)
7.3.2 Europe Patent Drug Market Size by Application (2024-2034)
7.3.3 Europe Patent Drug Market Share by Application (2018-2034)
7.4 Europe Patent Drug Market Size by Country
7.4.1 Europe Patent Drug Market Size by Country: 2018 VS 2022 VS 2034
7.4.2 Europe Patent Drug Market Size by Country (2018-2024)
7.4.3 Europe Patent Drug Market Size by Country (2024-2034)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Patent Drug Market Size (2018-2034)
8.2 China Patent Drug Market Size by Type
8.2.1 China Patent Drug Market Size by Type (2018-2024)
8.2.2 China Patent Drug Market Size by Type (2024-2034)
8.2.3 China Patent Drug Market Share by Type (2018-2034)
8.3 China Patent Drug Market Size by Application
8.3.1 China Patent Drug Market Size by Application (2018-2024)
8.3.2 China Patent Drug Market Size by Application (2024-2034)
8.3.3 China Patent Drug Market Share by Application (2018-2034)
9 Asia (excluding China)
9.1 Asia Patent Drug Market Size (2018-2034)
9.2 Asia Patent Drug Market Size by Type
9.2.1 Asia Patent Drug Market Size by Type (2018-2024)
9.2.2 Asia Patent Drug Market Size by Type (2024-2034)
9.2.3 Asia Patent Drug Market Share by Type (2018-2034)
9.3 Asia Patent Drug Market Size by Application
9.3.1 Asia Patent Drug Market Size by Application (2018-2024)
9.3.2 Asia Patent Drug Market Size by Application (2024-2034)
9.3.3 Asia Patent Drug Market Share by Application (2018-2034)
9.4 Asia Patent Drug Market Size by Region
9.4.1 Asia Patent Drug Market Size by Region: 2018 VS 2022 VS 2034
9.4.2 Asia Patent Drug Market Size by Region (2018-2024)
9.4.3 Asia Patent Drug Market Size by Region (2024-2034)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Patent Drug Market Size (2018-2034)
10.2 Middle East, Africa, and Latin America Patent Drug Market Size by Type
10.2.1 Middle East, Africa, and Latin America Patent Drug Market Size by Type (2018-2024)
10.2.2 Middle East, Africa, and Latin America Patent Drug Market Size by Type (2024-2034)
10.2.3 Middle East, Africa, and Latin America Patent Drug Market Share by Type (2018-2034)
10.3 Middle East, Africa, and Latin America Patent Drug Market Size by Application
10.3.1 Middle East, Africa, and Latin America Patent Drug Market Size by Application (2018-2024)
10.3.2 Middle East, Africa, and Latin America Patent Drug Market Size by Application (2024-2034)
10.3.3 Middle East, Africa, and Latin America Patent Drug Market Share by Application (2018-2034)
10.4 Middle East, Africa, and Latin America Patent Drug Market Size by Country
10.4.1 Middle East, Africa, and Latin America Patent Drug Market Size by Country: 2018 VS 2022 VS 2034
10.4.2 Middle East, Africa, and Latin America Patent Drug Market Size by Country (2018-2024)
10.4.3 Middle East, Africa, and Latin America Patent Drug Market Size by Country (2024-2034)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Johnson & Johnson
11.1.1 Johnson & Johnson Company Details
11.1.2 Johnson & Johnson Business Overview
11.1.3 Johnson & Johnson Patent Drug Introduction
11.1.4 Johnson & Johnson Revenue in Patent Drug Business (2018-2024)
11.1.5 Johnson & Johnson Recent Developments
11.2 Novartis
11.2.1 Novartis Company Details
11.2.2 Novartis Business Overview
11.2.3 Novartis Patent Drug Introduction
11.2.4 Novartis Revenue in Patent Drug Business (2018-2024)
11.2.5 Novartis Recent Developments
11.3 Roche
11.3.1 Roche Company Details
11.3.2 Roche Business Overview
11.3.3 Roche Patent Drug Introduction
11.3.4 Roche Revenue in Patent Drug Business (2018-2024)
11.3.5 Roche Recent Developments
11.4 AbbVie
11.4.1 AbbVie Company Details
11.4.2 AbbVie Business Overview
11.4.3 AbbVie Patent Drug Introduction
11.4.4 AbbVie Revenue in Patent Drug Business (2018-2024)
11.4.5 AbbVie Recent Developments
11.5 Merck & Co.
11.5.1 Merck & Co. Company Details
11.5.2 Merck & Co. Business Overview
11.5.3 Merck & Co. Patent Drug Introduction
11.5.4 Merck & Co. Revenue in Patent Drug Business (2018-2024)
11.5.5 Merck & Co. Recent Developments
11.6 Bristol Myers Squibb
11.6.1 Bristol Myers Squibb Company Details
11.6.2 Bristol Myers Squibb Business Overview
11.6.3 Bristol Myers Squibb Patent Drug Introduction
11.6.4 Bristol Myers Squibb Revenue in Patent Drug Business (2018-2024)
11.6.5 Bristol Myers Squibb Recent Developments
11.7 GlaxoSmithKline
11.7.1 GlaxoSmithKline Company Details
11.7.2 GlaxoSmithKline Business Overview
11.7.3 GlaxoSmithKline Patent Drug Introduction
11.7.4 GlaxoSmithKline Revenue in Patent Drug Business (2018-2024)
11.7.5 GlaxoSmithKline Recent Developments
11.8 Pfizer
11.8.1 Pfizer Company Details
11.8.2 Pfizer Business Overview
11.8.3 Pfizer Patent Drug Introduction
11.8.4 Pfizer Revenue in Patent Drug Business (2018-2024)
11.8.5 Pfizer Recent Developments
11.9 Sanofi
11.9.1 Sanofi Company Details
11.9.2 Sanofi Business Overview
11.9.3 Sanofi Patent Drug Introduction
11.9.4 Sanofi Revenue in Patent Drug Business (2018-2024)
11.9.5 Sanofi Recent Developments
11.10 Takeda
11.10.1 Takeda Company Details
11.10.2 Takeda Business Overview
11.10.3 Takeda Patent Drug Introduction
11.10.4 Takeda Revenue in Patent Drug Business (2018-2024)
11.10.5 Takeda Recent Developments
11.11 AstraZeneca
11.11.1 AstraZeneca Company Details
11.11.2 AstraZeneca Business Overview
11.11.3 AstraZeneca Patent Drug Introduction
11.11.4 AstraZeneca Revenue in Patent Drug Business (2018-2024)
11.11.5 AstraZeneca Recent Developments
11.12 Bayer
11.12.1 Bayer Company Details
11.12.2 Bayer Business Overview
11.12.3 Bayer Patent Drug Introduction
11.12.4 Bayer Revenue in Patent Drug Business (2018-2024)
11.12.5 Bayer Recent Developments
11.13 Eli Lilly & Co.
11.13.1 Eli Lilly & Co. Company Details
11.13.2 Eli Lilly & Co. Business Overview
11.13.3 Eli Lilly & Co. Patent Drug Introduction
11.13.4 Eli Lilly & Co. Revenue in Patent Drug Business (2018-2024)
11.13.5 Eli Lilly & Co. Recent Developments
11.14 Gilead Sciences
11.14.1 Gilead Sciences Company Details
11.14.2 Gilead Sciences Business Overview
11.14.3 Gilead Sciences Patent Drug Introduction
11.14.4 Gilead Sciences Revenue in Patent Drug Business (2018-2024)
11.14.5 Gilead Sciences Recent Developments
11.15 Amgen
11.15.1 Amgen Company Details
11.15.2 Amgen Business Overview
11.15.3 Amgen Patent Drug Introduction
11.15.4 Amgen Revenue in Patent Drug Business (2018-2024)
11.15.5 Amgen Recent Developments
11.16 Novo Nordisk
11.16.1 Novo Nordisk Company Details
11.16.2 Novo Nordisk Business Overview
11.16.3 Novo Nordisk Patent Drug Introduction
11.16.4 Novo Nordisk Revenue in Patent Drug Business (2018-2024)
11.16.5 Novo Nordisk Recent Developments
11.17 Teva
11.17.1 Teva Company Details
11.17.2 Teva Business Overview
11.17.3 Teva Patent Drug Introduction
11.17.4 Teva Revenue in Patent Drug Business (2018-2024)
11.17.5 Teva Recent Developments
11.18 Boehringer Ingelheim
11.18.1 Boehringer Ingelheim Company Details
11.18.2 Boehringer Ingelheim Business Overview
11.18.3 Boehringer Ingelheim Patent Drug Introduction
11.18.4 Boehringer Ingelheim Revenue in Patent Drug Business (2018-2024)
11.18.5 Boehringer Ingelheim Recent Developments
11.19 Biogen
11.19.1 Biogen Company Details
11.19.2 Biogen Business Overview
11.19.3 Biogen Patent Drug Introduction
11.19.4 Biogen Revenue in Patent Drug Business (2018-2024)
11.19.5 Biogen Recent Developments
11.20 Astellas
11.20.1 Astellas Company Details
11.20.2 Astellas Business Overview
11.20.3 Astellas Patent Drug Introduction
11.20.4 Astellas Revenue in Patent Drug Business (2018-2024)
11.20.5 Astellas Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Patent Drug Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2034
Table 2. Key Players of Oral
Table 3. Key Players of Injection
Table 4. Key Players of Other
Table 5. Global Patent Drug Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2034
Table 6. Global Patent Drug Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2034
Table 7. Global Patent Drug Market Size by Region (2018-2024) & (US$ Million)
Table 8. Global Patent Drug Market Share by Region (2018-2024)
Table 9. Global Patent Drug Forecasted Market Size by Region (2024-2034) & (US$ Million)
Table 10. Global Patent Drug Market Share by Region (2024-2034)
Table 11. Patent Drug Market Trends
Table 12. Patent Drug Market Drivers
Table 13. Patent Drug Market Challenges
Table 14. Patent Drug Market Restraints
Table 15. Global Patent Drug Revenue by Players (2018-2024) & (US$ Million)
Table 16. Global Patent Drug Revenue Share by Players (2018-2024)
Table 17. Global Top Patent Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Patent Drug as of 2022)
Table 18. Global Patent Drug Industry Ranking 2021 VS 2022 VS 2024
Table 19. Global 5 Largest Players Market Share by Patent Drug Revenue (CR5 and HHI) & (2018-2024)
Table 20. Global Key Players of Patent Drug, Headquarters and Area Served
Table 21. Global Key Players of Patent Drug, Product and Application
Table 22. Global Key Players of Patent Drug, Product and Application
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Patent Drug Market Size by Type (2018-2024) & (US$ Million)
Table 25. Global Patent Drug Revenue Market Share by Type (2018-2024)
Table 26. Global Patent Drug Forecasted Market Size by Type (2024-2034) & (US$ Million)
Table 27. Global Patent Drug Revenue Market Share by Type (2024-2034)
Table 28. Global Patent Drug Market Size by Application (2018-2024) & (US$ Million)
Table 29. Global Patent Drug Revenue Share by Application (2018-2024)
Table 30. Global Patent Drug Forecasted Market Size by Application (2024-2034) & (US$ Million)
Table 31. Global Patent Drug Revenue Share by Application (2024-2034)
Table 32. North America Patent Drug Market Size by Type (2018-2024) & (US$ Million)
Table 33. North America Patent Drug Market Size by Type (2024-2034) & (US$ Million)
Table 34. North America Patent Drug Market Size by Application (2018-2024) & (US$ Million)
Table 35. North America Patent Drug Market Size by Application (2024-2034) & (US$ Million)
Table 36. North America Patent Drug Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2034
Table 37. North America Patent Drug Market Size by Country (2018-2024) & (US$ Million)
Table 38. North America Patent Drug Market Size by Country (2024-2034) & (US$ Million)
Table 39. Europe Patent Drug Market Size by Type (2018-2024) & (US$ Million)
Table 40. Europe Patent Drug Market Size by Type (2024-2034) & (US$ Million)
Table 41. Europe Patent Drug Market Size by Application (2018-2024) & (US$ Million)
Table 42. Europe Patent Drug Market Size by Application (2024-2034) & (US$ Million)
Table 43. Europe Patent Drug Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2034
Table 44. Europe Patent Drug Market Size by Country (2018-2024) & (US$ Million)
Table 45. Europe Patent Drug Market Size by Country (2024-2034) & (US$ Million)
Table 46. China Patent Drug Market Size by Type (2018-2024) & (US$ Million)
Table 47. China Patent Drug Market Size by Type (2024-2034) & (US$ Million)
Table 48. China Patent Drug Market Size by Application (2018-2024) & (US$ Million)
Table 49. China Patent Drug Market Size by Application (2024-2034) & (US$ Million)
Table 50. Asia Patent Drug Market Size by Type (2018-2024) & (US$ Million)
Table 51. Asia Patent Drug Market Size by Type (2024-2034) & (US$ Million)
Table 52. Asia Patent Drug Market Size by Application (2018-2024) & (US$ Million)
Table 53. Asia Patent Drug Market Size by Application (2024-2034) & (US$ Million)
Table 54. Asia Patent Drug Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2034
Table 55. Asia Patent Drug Market Size by Region (2018-2024) & (US$ Million)
Table 56. Asia Patent Drug Market Size by Region (2024-2034) & (US$ Million)
Table 57. Middle East, Africa, and Latin America Patent Drug Market Size by Type (2018-2024) & (US$ Million)
Table 58. Middle East, Africa, and Latin America Patent Drug Market Size by Type (2024-2034) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Patent Drug Market Size by Application (2018-2024) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Patent Drug Market Size by Application (2024-2034) & (US$ Million)
Table 61. Middle East, Africa, and Latin America Patent Drug Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2034
Table 62. Middle East, Africa, and Latin America Patent Drug Market Size by Country (2018-2024) & (US$ Million)
Table 63. Middle East, Africa, and Latin America Patent Drug Market Size by Country (2024-2034) & (US$ Million)
Table 64. Johnson & Johnson Company Details
Table 65. Johnson & Johnson Business Overview
Table 66. Johnson & Johnson Patent Drug Product
Table 67. Johnson & Johnson Revenue in Patent Drug Business (2018-2024) & (US$ Million)
Table 68. Johnson & Johnson Recent Developments
Table 69. Novartis Company Details
Table 70. Novartis Business Overview
Table 71. Novartis Patent Drug Product
Table 72. Novartis Revenue in Patent Drug Business (2018-2024) & (US$ Million)
Table 73. Novartis Recent Developments
Table 74. Roche Company Details
Table 75. Roche Business Overview
Table 76. Roche Patent Drug Product
Table 77. Roche Revenue in Patent Drug Business (2018-2024) & (US$ Million)
Table 78. Roche Recent Developments
Table 79. AbbVie Company Details
Table 80. AbbVie Business Overview
Table 81. AbbVie Patent Drug Product
Table 82. AbbVie Revenue in Patent Drug Business (2018-2024) & (US$ Million)
Table 83. AbbVie Recent Developments
Table 84. Merck & Co. Company Details
Table 85. Merck & Co. Business Overview
Table 86. Merck & Co. Patent Drug Product
Table 87. Merck & Co. Revenue in Patent Drug Business (2018-2024) & (US$ Million)
Table 88. Merck & Co. Recent Developments
Table 89. Bristol Myers Squibb Company Details
Table 90. Bristol Myers Squibb Business Overview
Table 91. Bristol Myers Squibb Patent Drug Product
Table 92. Bristol Myers Squibb Revenue in Patent Drug Business (2018-2024) & (US$ Million)
Table 93. Bristol Myers Squibb Recent Developments
Table 94. GlaxoSmithKline Company Details
Table 95. GlaxoSmithKline Business Overview
Table 96. GlaxoSmithKline Patent Drug Product
Table 97. GlaxoSmithKline Revenue in Patent Drug Business (2018-2024) & (US$ Million)
Table 98. GlaxoSmithKline Recent Developments
Table 99. Pfizer Company Details
Table 100. Pfizer Business Overview
Table 101. Pfizer Patent Drug Product
Table 102. Pfizer Revenue in Patent Drug Business (2018-2024) & (US$ Million)
Table 103. Pfizer Recent Developments
Table 104. Sanofi Company Details
Table 105. Sanofi Business Overview
Table 106. Sanofi Patent Drug Product
Table 107. Sanofi Revenue in Patent Drug Business (2018-2024) & (US$ Million)
Table 108. Sanofi Recent Developments
Table 109. Takeda Company Details
Table 110. Takeda Business Overview
Table 111. Takeda Patent Drug Product
Table 112. Takeda Revenue in Patent Drug Business (2018-2024) & (US$ Million)
Table 113. Takeda Recent Developments
Table 114. AstraZeneca Company Details
Table 115. AstraZeneca Business Overview
Table 116. AstraZeneca Patent Drug Product
Table 117. AstraZeneca Revenue in Patent Drug Business (2018-2024) & (US$ Million)
Table 118. AstraZeneca Recent Developments
Table 119. Bayer Company Details
Table 120. Bayer Business Overview
Table 121. Bayer Patent Drug Product
Table 122. Bayer Revenue in Patent Drug Business (2018-2024) & (US$ Million)
Table 123. Bayer Recent Developments
Table 124. Eli Lilly & Co. Company Details
Table 125. Eli Lilly & Co. Business Overview
Table 126. Eli Lilly & Co. Patent Drug Product
Table 127. Eli Lilly & Co. Revenue in Patent Drug Business (2018-2024) & (US$ Million)
Table 128. Eli Lilly & Co. Recent Developments
Table 129. Gilead Sciences Company Details
Table 130. Gilead Sciences Business Overview
Table 131. Gilead Sciences Patent Drug Product
Table 132. Gilead Sciences Revenue in Patent Drug Business (2018-2024) & (US$ Million)
Table 133. Gilead Sciences Recent Developments
Table 134. Amgen Company Details
Table 135. Amgen Business Overview
Table 136. Amgen Patent Drug Product
Table 137. Amgen Revenue in Patent Drug Business (2018-2024) & (US$ Million)
Table 138. Amgen Recent Developments
Table 139. Novo Nordisk Company Details
Table 140. Novo Nordisk Business Overview
Table 141. Novo Nordisk Patent Drug Product
Table 142. Novo Nordisk Revenue in Patent Drug Business (2018-2024) & (US$ Million)
Table 143. Novo Nordisk Recent Developments
Table 144. Teva Company Details
Table 145. Teva Business Overview
Table 146. Teva Patent Drug Product
Table 147. Teva Revenue in Patent Drug Business (2018-2024) & (US$ Million)
Table 148. Teva Recent Developments
Table 149. Boehringer Ingelheim Company Details
Table 150. Boehringer Ingelheim Business Overview
Table 151. Boehringer Ingelheim Patent Drug Product
Table 152. Boehringer Ingelheim Revenue in Patent Drug Business (2018-2024) & (US$ Million)
Table 153. Boehringer Ingelheim Recent Developments
Table 154. Biogen Company Details
Table 155. Biogen Business Overview
Table 156. Biogen Patent Drug Product
Table 157. Biogen Revenue in Patent Drug Business (2018-2024) & (US$ Million)
Table 158. Biogen Recent Developments
Table 159. Astellas Company Details
Table 160. Astellas Business Overview
Table 161. Astellas Patent Drug Product
Table 162. Astellas Revenue in Patent Drug Business (2018-2024) & (US$ Million)
Table 163. Astellas Recent Developments
Table 164. Research Programs/Design for This Report
Table 165. Key Data Information from Secondary Sources
Table 166. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Patent Drug Market Size Growth Rate by Type, 2018 VS 2022 VS 2034 (US$ Million)
Figure 2. Global Patent Drug Market Share by Type: 2022 VS 2034
Figure 3. Oral Features
Figure 4. Injection Features
Figure 5. Other Features
Figure 6. Global Patent Drug Market Size Growth Rate by Application, 2018 VS 2022 VS 2034 (US$ Million)
Figure 7. Global Patent Drug Market Share by Application: 2022 VS 2034
Figure 8. Hospital Case Studies
Figure 9. Retail Pharmacy Case Studies
Figure 10. Patent Drug Report Years Considered
Figure 11. Global Patent Drug Market Size (US$ Million), Year-over-Year: 2018-2034
Figure 12. Global Patent Drug Market Size, (US$ Million), 2018 VS 2022 VS 2034
Figure 13. Global Patent Drug Market Share by Region: 2022 VS 2034
Figure 14. Global Patent Drug Market Share by Players in 2022
Figure 15. Global Top Patent Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Patent Drug as of 2022)
Figure 16. The Top 10 and 5 Players Market Share by Patent Drug Revenue in 2022
Figure 17. North America Patent Drug Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 18. North America Patent Drug Market Share by Type (2018-2034)
Figure 19. North America Patent Drug Market Share by Application (2018-2034)
Figure 20. North America Patent Drug Market Share by Country (2018-2034)
Figure 21. United States Patent Drug Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 22. Canada Patent Drug Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 23. Europe Patent Drug Market Size YoY (2018-2034) & (US$ Million)
Figure 24. Europe Patent Drug Market Share by Type (2018-2034)
Figure 25. Europe Patent Drug Market Share by Application (2018-2034)
Figure 26. Europe Patent Drug Market Share by Country (2018-2034)
Figure 27. Germany Patent Drug Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 28. France Patent Drug Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 29. U.K. Patent Drug Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 30. Italy Patent Drug Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 31. Russia Patent Drug Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 32. Nordic Countries Patent Drug Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 33. China Patent Drug Market Size YoY (2018-2034) & (US$ Million)
Figure 34. China Patent Drug Market Share by Type (2018-2034)
Figure 35. China Patent Drug Market Share by Application (2018-2034)
Figure 36. Asia Patent Drug Market Size YoY (2018-2034) & (US$ Million)
Figure 37. Asia Patent Drug Market Share by Type (2018-2034)
Figure 38. Asia Patent Drug Market Share by Application (2018-2034)
Figure 39. Asia Patent Drug Market Share by Region (2018-2034)
Figure 40. Japan Patent Drug Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 41. South Korea Patent Drug Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 42. China Taiwan Patent Drug Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 43. Southeast Asia Patent Drug Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 44. India Patent Drug Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 45. Australia Patent Drug Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 46. Middle East, Africa, and Latin America Patent Drug Market Size YoY (2018-2034) & (US$ Million)
Figure 47. Middle East, Africa, and Latin America Patent Drug Market Share by Type (2018-2034)
Figure 48. Middle East, Africa, and Latin America Patent Drug Market Share by Application (2018-2034)
Figure 49. Middle East, Africa, and Latin America Patent Drug Market Share by Country (2018-2034)
Figure 50. Brazil Patent Drug Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 51. Mexico Patent Drug Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 52. Turkey Patent Drug Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 53. Saudi Arabia Patent Drug Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 54. Israel Patent Drug Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 55. GCC Countries Patent Drug Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 56. Johnson & Johnson Revenue Growth Rate in Patent Drug Business (2018-2024)
Figure 57. Novartis Revenue Growth Rate in Patent Drug Business (2018-2024)
Figure 58. Roche Revenue Growth Rate in Patent Drug Business (2018-2024)
Figure 59. AbbVie Revenue Growth Rate in Patent Drug Business (2018-2024)
Figure 60. Merck & Co. Revenue Growth Rate in Patent Drug Business (2018-2024)
Figure 61. Bristol Myers Squibb Revenue Growth Rate in Patent Drug Business (2018-2024)
Figure 62. GlaxoSmithKline Revenue Growth Rate in Patent Drug Business (2018-2024)
Figure 63. Pfizer Revenue Growth Rate in Patent Drug Business (2018-2024)
Figure 64. Sanofi Revenue Growth Rate in Patent Drug Business (2018-2024)
Figure 65. Takeda Revenue Growth Rate in Patent Drug Business (2018-2024)
Figure 66. AstraZeneca Revenue Growth Rate in Patent Drug Business (2018-2024)
Figure 67. Bayer Revenue Growth Rate in Patent Drug Business (2018-2024)
Figure 68. Eli Lilly & Co. Revenue Growth Rate in Patent Drug Business (2018-2024)
Figure 69. Gilead Sciences Revenue Growth Rate in Patent Drug Business (2018-2024)
Figure 70. Amgen Revenue Growth Rate in Patent Drug Business (2018-2024)
Figure 71. Novo Nordisk Revenue Growth Rate in Patent Drug Business (2018-2024)
Figure 72. Teva Revenue Growth Rate in Patent Drug Business (2018-2024)
Figure 73. Boehringer Ingelheim Revenue Growth Rate in Patent Drug Business (2018-2024)
Figure 74. Biogen Revenue Growth Rate in Patent Drug Business (2018-2024)
Figure 75. Astellas Revenue Growth Rate in Patent Drug Business (2018-2024)
Figure 76. Bottom-up and Top-down Approaches for This Report
Figure 77. Data Triangulation
Figure 78. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries